Organic Recycling Systems to Raise INR 16.10 Crore via Promoter Share Issue

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Organic Recycling Systems to Raise INR 16.10 Crore via Promoter Share Issue

Organic Recycling Systems has approved a preferential issue of 10 lakh equity shares to promoter Sarang Bhand at INR 161 per share. This move will boost the promoter's stake from 15.07% to 20.19% and inject INR 16.10 crore into the company. The plan awaits shareholder approval at the upcoming AGM on September 30, 2026.

Organic Recycling Systems Approves INR 16.10 Crore Preferential Issue

Organic Recycling Systems Ltd is set to raise INR 16.10 crore through a preferential issue of 10 lakh equity shares.

Reader Takeaway: Promoter increases stake to 20.19%, signaling confidence, while the firm gains fresh capital for business growth initiatives.

What just happened

The Board of Directors of Organic Recycling Systems approved the issuance of 10,00,000 fully paid-up equity shares at a price of INR 161 per share. The issue price includes a premium of INR 151 over the face value of INR 10. The price sits above the SEBI-mandated floor price of INR 160.01 per share. The shares are being issued specifically to promoter Mr. Sarang Bhand.

Why this matters

The capital injection of INR 16.10 crore is intended to strengthen the company’s balance sheet. Furthermore, the increase in promoter holding from 15.07% to 20.19% acts as a signal of internal confidence in the company’s future prospects. Such capital raises are typically used to fund expansion, working capital, or debt reduction.

What changes now

Following the board approval, the company must now secure the green light from its shareholders. An Annual General Meeting (AGM) has been scheduled for September 30, 2026, where the proposal will be put to a vote. Following this, regulatory and statutory approvals will be completed before the fund infusion is finalized.

What to track next

Investors should closely monitor the AGM results on September 30, 2026. Once approved, the actual timeline for fund infusion and the subsequent deployment of the capital into the company's operational projects will be the primary metrics for gauging impact on long-term performance.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.